Annual CFI
-$14.30 K
-$200.00-1.42%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual cash flow from investing activities is -$14.30 thousand, with the most recent change of -$200.00 (-1.42%) on December 31, 2023.
- During the last 3 years, HEPA annual CFI has risen by +$71.50 thousand (+83.33%).
- HEPA annual CFI is now -1688.89% below its all-time high of $900.00, reached on December 31, 2018.
Performance
HEPA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$600.00 K
-$600.00 K-100.00%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly cash flow from investing activities is -$600.00 thousand, with the most recent change of -$600.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, HEPA quarterly CFI has dropped by -$602.60 thousand (-23176.92%).
- HEPA quarterly CFI is now -23176.92% below its all-time high of $2600.00, reached on September 30, 2023.
Performance
HEPA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$600.30 K
-$602.60 K-26200.00%
September 30, 2024
Summary
- As of February 7, 2025, HEPA TTM cash flow from investing activities is -$600.30 thousand, with the most recent change of -$602.60 thousand (-26200.00%) on September 30, 2024.
- Over the past year, HEPA TTM CFI has dropped by -$570.10 thousand (-1887.75%).
- HEPA TTM CFI is now -26200.00% below its all-time high of $2300.00, reached on September 30, 2022.
Performance
HEPA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
HEPA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.4% | -10000.0% | -1887.8% |
| 3 y3 years | +83.3% | -100.0% | -360.4% |
| 5 y5 years | -1688.9% | -100.0% | -360.4% |
HEPA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.4% | +89.0% | <-9999.0% | at low | <-9999.0% | at low |
| 5 y | 5-year | -1.4% | +89.0% | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | -1688.9% | +97.2% | <-9999.0% | at low | <-9999.0% | at low |
Hepion Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$600.00 K(<-9900.0%) | -$600.30 K(<-9900.0%) |
| Jun 2024 | - | $0.00(0.0%) | $2300.00(-116.2%) |
| Mar 2024 | - | $0.00(-100.0%) | -$14.20 K(0.0%) |
| Dec 2023 | -$14.30 K(+1.4%) | -$300.00(-111.5%) | -$14.20 K(-53.0%) |
| Sep 2023 | - | $2600.00(-115.8%) | -$30.20 K(-7.9%) |
| Jun 2023 | - | -$16.50 K(<-9900.0%) | -$32.80 K(+134.3%) |
| Mar 2023 | - | $0.00(-100.0%) | -$14.00 K(0.0%) |
| Dec 2022 | -$14.10 K(-89.2%) | -$16.30 K(<-9900.0%) | -$14.00 K(-708.7%) |
| Sep 2022 | - | $0.00(-100.0%) | $2300.00(-106.7%) |
| Jun 2022 | - | $2300.00(>+9900.0%) | -$34.20 K(-29.2%) |
| Mar 2022 | - | $0.00(0.0%) | -$48.30 K(-63.0%) |
| Dec 2021 | -$130.40 K(+52.0%) | $0.00(-100.0%) | -$130.40 K(-37.0%) |
| Sep 2021 | - | -$36.50 K(+209.3%) | -$206.90 K(+21.4%) |
| Jun 2021 | - | -$11.80 K(-85.6%) | -$170.40 K(+0.2%) |
| Mar 2021 | - | -$82.10 K(+7.3%) | -$170.00 K(+98.4%) |
| Dec 2020 | -$85.80 K(+66.6%) | -$76.50 K(<-9900.0%) | -$85.70 K(+460.1%) |
| Sep 2020 | - | $0.00(-100.0%) | -$15.30 K(0.0%) |
| Jun 2020 | - | -$11.40 K(-618.2%) | -$15.30 K(+34.2%) |
| Mar 2020 | - | $2200.00(-136.1%) | -$11.40 K(-77.8%) |
| Dec 2019 | -$51.50 K | -$6100.00(<-9900.0%) | -$51.40 K(+13.5%) |
| Sep 2019 | - | $0.00(-100.0%) | -$45.30 K(0.0%) |
| Jun 2019 | - | -$7500.00(-80.2%) | -$45.30 K(+19.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$37.80 K(<-9900.0%) | -$37.80 K(-4300.0%) |
| Dec 2018 | $900.00(>+9900.0%) | $0.00(0.0%) | $900.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $900.00(0.0%) |
| Jun 2018 | - | $0.00(-100.0%) | $900.00(-160.0%) |
| Mar 2018 | - | $900.00(>+9900.0%) | -$1500.00(-89.8%) |
| Dec 2017 | $0.00(-100.0%) | - | - |
| Sep 2017 | - | $0.00(-100.0%) | -$14.70 K(0.0%) |
| Jun 2017 | -$14.70 K(-97.1%) | -$2400.00(<-9900.0%) | -$14.70 K(-97.1%) |
| Mar 2017 | - | $0.00(-100.0%) | -$507.90 K(0.0%) |
| Dec 2016 | - | -$12.30 K(<-9900.0%) | -$507.90 K(+2.5%) |
| Sep 2016 | - | $0.00(-100.0%) | -$495.60 K(-1.3%) |
| Jun 2016 | -$502.20 K(+502.9%) | -$495.60 K(<-9900.0%) | -$502.20 K(+7509.1%) |
| Mar 2016 | - | $0.00(0.0%) | -$6600.00(-81.5%) |
| Dec 2015 | - | $0.00(-100.0%) | -$35.70 K(-22.6%) |
| Sep 2015 | - | -$6600.00(<-9900.0%) | -$46.10 K(-44.7%) |
| Jun 2015 | -$83.30 K(+427.2%) | $0.00(-100.0%) | -$83.30 K(0.0%) |
| Mar 2015 | - | -$29.10 K(+179.8%) | -$83.30 K(+19.0%) |
| Dec 2014 | - | -$10.40 K(-76.3%) | -$70.00 K(+17.4%) |
| Sep 2014 | - | -$43.80 K(<-9900.0%) | -$59.60 K(+277.2%) |
| Jun 2014 | -$15.80 K | $0.00(-100.0%) | -$15.80 K(0.0%) |
| Mar 2014 | - | -$15.80 K(<-9900.0%) | -$15.80 K(<-9900.0%) |
| Dec 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00 | $0.00 |
FAQ
- What is Hepion Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual CFI year-on-year change?
- What is Hepion Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly CFI year-on-year change?
- What is Hepion Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM CFI year-on-year change?
What is Hepion Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of HEPA is -$14.30 K
What is the all time high annual CFI for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual cash flow from investing activities is $900.00
What is Hepion Pharmaceuticals annual CFI year-on-year change?
Over the past year, HEPA annual cash flow from investing activities has changed by -$200.00 (-1.42%)
What is Hepion Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of HEPA is -$600.00 K
What is the all time high quarterly CFI for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly cash flow from investing activities is $2600.00
What is Hepion Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, HEPA quarterly cash flow from investing activities has changed by -$602.60 K (-23176.92%)
What is Hepion Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of HEPA is -$600.30 K
What is the all time high TTM CFI for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM cash flow from investing activities is $2300.00
What is Hepion Pharmaceuticals TTM CFI year-on-year change?
Over the past year, HEPA TTM cash flow from investing activities has changed by -$570.10 K (-1887.75%)